Ensysce Biosciences Statistics
Total Valuation
ENSC has a market cap or net worth of $8.14 million. The enterprise value is -$21.38 million.
| Market Cap | 8.14M |
| Enterprise Value | -21.38M |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENSC has 19.46 million shares outstanding. The number of shares has increased by 441.64% in one year.
| Current Share Class | 19.46M |
| Shares Outstanding | 19.46M |
| Shares Change (YoY) | +441.64% |
| Shares Change (QoQ) | +39.56% |
| Owned by Insiders (%) | 4.72% |
| Owned by Institutions (%) | 7.12% |
| Float | 18.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| Forward PS | 1.90 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.02, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.02 |
| Quick Ratio | 7.74 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -901.14 |
Financial Efficiency
Return on equity (ROE) is -651.84% and return on invested capital (ROIC) is -50.43%.
| Return on Equity (ROE) | -651.84% |
| Return on Assets (ROA) | -42.15% |
| Return on Invested Capital (ROIC) | -50.43% |
| Return on Capital Employed (ROCE) | -42.45% |
| Weighted Average Cost of Capital (WACC) | 10.20% |
| Revenue Per Employee | $618,928 |
| Profits Per Employee | -$9.12M |
| Employee Count | 10 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.69% in the last 52 weeks. The beta is 1.09, so ENSC's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -79.69% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.41 |
| Relative Strength Index (RSI) | 50.15 |
| Average Volume (20 Days) | 296,115 |
Short Selling Information
The latest short interest is 88,607, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 88,607 |
| Short Previous Month | 303,956 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, ENSC had revenue of $6.19 million and -$91.21 million in losses. Loss per share was -$8.71.
| Revenue | 6.19M |
| Gross Profit | -4.19M |
| Operating Income | -11.51M |
| Pretax Income | -91.21M |
| Net Income | -91.21M |
| EBITDA | n/a |
| EBIT | -11.51M |
| Loss Per Share | -$8.71 |
Balance Sheet
The company has $29.67 million in cash and $154,874 in debt, with a net cash position of $29.52 million or $1.52 per share.
| Cash & Cash Equivalents | 29.67M |
| Total Debt | 154,874 |
| Net Cash | 29.52M |
| Net Cash Per Share | $1.52 |
| Equity (Book Value) | 27.11M |
| Book Value Per Share | 1.41 |
| Working Capital | 26.96M |
Cash Flow
In the last 12 months, operating cash flow was -$8.39 million and capital expenditures -$51,748, giving a free cash flow of -$8.44 million.
| Operating Cash Flow | -8.39M |
| Capital Expenditures | -51,748 |
| Depreciation & Amortization | 26,132 |
| Net Borrowing | -214,076 |
| Free Cash Flow | -8.44M |
| FCF Per Share | -$0.43 |
Margins
| Gross Margin | -67.66% |
| Operating Margin | -185.96% |
| Pretax Margin | -1,473.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | -185.96% |
| FCF Margin | n/a |
Dividends & Yields
ENSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -441.64% |
| Shareholder Yield | n/a |
| Earnings Yield | -2,080.94% |
| FCF Yield | -103.65% |
Analyst Forecast
The average price target for ENSC is $4.08, which is 875.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.08 |
| Price Target Difference | 875.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on December 6, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | Dec 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |